ViaWealth’s Thermo Fisher Scientific TMO Stock Holding History

ViaWealth’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$411K	Hold	820	–	–	0.21%	121
2026 Q1	$403K	Hold	820	–	–	0.22%	116
2025 Q4	$475K	Sell	820 -40	-5%	-$22.6K	0.27%	102
2025 Q3	$417K	Sell	860 -159	-16%	-$74K	0.23%	112
2025 Q2	$413K	Hold	1,019	–	–	0.24%	115
2025 Q1	$507K	Hold	1,019	–	–	0.31%	97
2024 Q4	$530K	Buy	1,019 +17	+2%	+$9.35K	0.32%	89
2024 Q3	$620K	Buy	1,002 +10	+1%	+$5.92K	0.36%	88
2024 Q2	$549K	Hold	992	–	–	0.34%	91
2024 Q1	$577K	Sell	992 -275	-22%	-$154K	0.36%	90
2023 Q4	$673K	Hold	1,267	–	–	0.46%	75
2023 Q3	$641K	Sell	1,267 -50	-4%	-$26.6K	0.47%	68
2023 Q2	$687K	Sell	1,317 -200	-13%	-$108K	0.51%	64
2023 Q1	$874K	Hold	1,517	–	–	0.69%	42
2022 Q4	$828K	Buy	+1,517	New	+$804K	0.68%	45

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

ViaWealth's TMO Position: Q2 2026 in Review

ViaWealth held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 820 shares worth $411K. The position accounts for 0.21% of the portfolio, ranked #121.

ViaWealth first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $874K in Q1 2023. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

ViaWealth held 820 shares of Thermo Fisher Scientific worth $411K as of Q2 2026.
ViaWealth left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.21% of ViaWealth's portfolio in Q2 2026, its #121 holding.
ViaWealth first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
ViaWealth's Thermo Fisher Scientific position peaked at $874K in Q1 2023.
2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on ViaWealth's 13F filing for Q2 2026, filed 11 Aug 2026.